TIP39
From Wikipedia, the free encyclopedia
Tuberoinfundibular 39 residue protein precursor
|
||||||||
Identifiers | ||||||||
Symbol(s) | TIP39; | |||||||
External IDs | OMIM: 608386 MGI: 2152297 HomoloGene: 14235 | |||||||
|
||||||||
Orthologs | ||||||||
Human | Mouse | |||||||
Entrez | 113091 | 114640 | ||||||
Ensembl | ENSG00000142538 | ENSMUSG00000038300 | ||||||
Uniprot | Q96A98 | Q91W27 | ||||||
Refseq | NM_178449 (mRNA) NP_848544 (protein) |
NM_053256 (mRNA) NP_444486 (protein) |
||||||
Location | Chr 19: 54.62 - 54.62 Mb | Chr 7: 45.05 - 45.05 Mb | ||||||
Pubmed search | [1] | [2] |
Tuberoinfundibular 39 residue protein precursor, also known as TIP39, is a human gene.[1]
TIP39 is related to parathyroid hormone (PTH; MIM 168450) and PTH-related protein (PTHRP; MIM 168470) and is a ligand for PTH receptor-2 (PTHR2; MIM 601469) (John et al., 2002).[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Usdin TB, Hoare SR, Wang T, et al. (1999). "TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus.". Nat. Neurosci. 2 (11): 941–3. doi: . PMID 10526330.
- Hoare SR, Clark JA, Usdin TB (2000). "Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity.". J. Biol. Chem. 275 (35): 27274–83. doi: . PMID 10854439.
- Dobolyi A, Ueda H, Uchida H, et al. (2002). "Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception.". Proc. Natl. Acad. Sci. U.S.A. 99 (3): 1651–6. doi: . PMID 11818570.
- John MR, Arai M, Rubin DA, et al. (2002). "Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues.". Endocrinology 143 (3): 1047–57. PMID 11861531.
- Hansen IA, Jakob O, Wortmann S, et al. (2002). "Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family.". J. Endocrinol. 174 (1): 95–102. PMID 12098667.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Della Penna K, Kinose F, Sun H, et al. (2003). "Tuberoinfundibular peptide of 39 residues (TIP39): molecular structure and activity for parathyroid hormone 2 receptor.". Neuropharmacology 44 (1): 141–53. PMID 12559132.
- Misiano P, Scott BB, Scheideler MA, Garnier M (2004). "PTH2 receptor-mediated inhibitory effect of parathyroid hormone and TIP39 on cell proliferation.". Eur. J. Pharmacol. 468 (3): 159–66. PMID 12754053.
- Bisello A, Manen D, Pierroz DD, et al. (2004). "Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.". Mol. Endocrinol. 18 (6): 1486–98. doi: . PMID 14988434.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.